Dr Maggie Cooper
Radiopharmacist/Qualified Person
Phone:
07555 782750
Email:
Address:
1 Orchard Road, Melbourn,
Royston, SG8 6HR
A Bit About Me
I qualified as a pharmacist in 1990 having studied at Aston University in Birmingham. My pre-registration training was with Glaxo Group Research/St Bartholomew's Hospital. I managed a community pharmacy before returning to Aston to study for my PhD where I developed peptide based tyrosine kinase inhibitors. After spending a few years as a basic grade pharmacist at the Royal Marsden, I found my passion in working with radioactive drugs as the first radiopharmacist at the Royal Free Hospital where I both developed the service and conducted research in collaboration with the Clinical Oncology and Haematology departments. It was an exciting time where we manufactured antibody conjugates to GMP for use in clinical trials for patients with haematological malignancies. I qualified as a transitional QP for release of radipharmaceutical IMPs under the grandfather clause in 2004 when the clinical trials regulations came into effect.
​
I undertook my MSc in Radiopharmaceutics and PET Radiochemistry at King's College London before taking a few years out to travel to China to teach English as a foreign language. I returned to King's as a Research Fellow using both my research skills and my regulatory knowledge to facilitate clinical trials within the PET centre and develop novel radiopharmaceuticals. I've extensive knowledge of working in the NHS having managed the Radiopharmacy units at the Royal Free Hospital, St Bartholomew's Hospital and the Royal Liverpool Hospital and having more recently been involved in setting up the gallium-68 service at St Bartholomew's.
​
I'm a member of the Royal Pharmaceutical Society, a registered pharmacist with the General Pharmaceutical Council, a member of the British Nuclear Medicine Society and secretary of the UK Radiopharmacy Group.
I am currently the Operations Manager for the Positron Emitting Radiopharmaceutical Laboratory at King's College London.
Outside of my regular work, I am a keen runner and chair of Warrior Pentathlon and Athletics Club. I host a running podcast called the E = mc2 of
Work Experience
2018 - 2022
2014 - 2017
2009 - 2014
2002 - 2006
1996 - 1999
Research Fellow, Translational Radiopharmacy, King’s College London, School of Biomedical Engineering and Imaging Sciences.
Responsible for liaising between the scientific and clinical teams to enable projects to translate from the laboratory to the clinic. Ensuring the novel tracers can be produced to GMP, preparing and helping to prepare paperwork necessary for submission of projects to MHRA for clinical trials. Responsible for areas relating to translating projects involving radiopharmacy to the clinical setting. Funded by the Centre for Medical Engineering at King’s College London (Wellcome and EPSRC funding).
Chief Radiopharmacist, Royal Liverpool and Broadgreen University Hospitals NHS Trust.
Head of the Radiopharmacy unit at RLUH producing radiopharmaceuticals for routine use and clinical trial use in Liverpool, Merseyside and Cheshire. Responsible for ensuring that products were made to GMP under a “specials” manufacturing licence and for research projects relating to radiopharmacy.
Research Fellow, Radiopharmacist/Radiochemist, King’s College London.
Funded by the Comprehensive Cancer Imaging Centre, involved in projects within Imaging Sciences relating to radiolabelling/ radiopharmacy and responsible for QA aspects of clinical trials within the PET centre.
Head of Radiopharmacy, Barts and the London NHS Trust
Responsible for running the Radiopharmacy in this busy London teaching hospital and restructuring the QMS. Oversight of the expansion of the service to include supply to external hospitals and the preparation of clinical trial material to GMP.
Head of Radiopharmacy, Royal Free Hospital, London
Head of the unit supplying radiopharmaceuticals to the Nuclear Medicine Department. The first full time radiopharmacist at the Royal Free. Responsible for developing and expanding the service. GMP production of radiolabelled antibodies for clinical trials in haematology.